| Inflammatory biomarkers in Alzheimer's disease plasma AR Morgan, S Touchard, C Leckey, C O'Hagan, AJ Nevado-Holgado, ... Alzheimer's & dementia 15 (6), 776-787, 2019 | 144 | 2019 |
| Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid P Takousis, A Sadlon, J Schulz, I Wohlers, V Dobricic, L Middleton, ... Alzheimer's & Dementia 15 (11), 1468-1477, 2019 | 122 | 2019 |
| Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics BM Tijms, J Gobom, L Reus, I Jansen, S Hong, V Dobricic, F Kilpert, ... Brain 143 (12), 3776-3792, 2020 | 118 | 2020 |
| Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum I Bos, S Vos, F Verhey, P Scheltens, C Teunissen, S Engelborghs, ... Alzheimer's & Dementia 15 (5), 644-654, 2019 | 111 | 2019 |
| A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease … D Stamate, M Kim, P Proitsi, S Westwood, A Baird, A Nevado‐Holgado, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 (1 …, 2019 | 104 | 2019 |
| Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease J Schulz, P Takousis, I Wohlers, IOG Itua, V Dobricic, G Rücker, H Binder, ... Annals of neurology 85 (6), 835-851, 2019 | 94 | 2019 |
| A hexanucleotide repeat modifies expressivity of X‐linked dystonia parkinsonism A Westenberger, CJ Reyes, G Saranza, V Dobricic, H Hanssen, ... Annals of Neurology 85 (6), 812-822, 2019 | 86 | 2019 |
| MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study M Ten Kate, A Redolfi, E Peira, I Bos, SJ Vos, R Vandenberghe, S Gabel, ... Alzheimer's research & therapy 10, 1-12, 2018 | 77 | 2018 |
| Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans K Lohmann, I Masuho, DN Patil, H Baumann, E Hebert, S Steinrücke, ... Human molecular genetics 26 (6), 1078-1086, 2017 | 68 | 2017 |
| Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease … M Kim, S Snowden, T Suvitaival, A Ali, DJ Merkler, T Ahmad, S Westwood, ... Alzheimer's & Dementia 15 (6), 817-827, 2019 | 66 | 2019 |
| Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay L Shi, S Westwood, AL Baird, L Winchester, V Dobricic, F Kilpert, S Hong, ... Alzheimer's & Dementia 15 (11), 1478-1488, 2019 | 56 | 2019 |
| Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1 V Rakocevic-Stojanovic, S Peric, R Madzarevic, V Dobricic, V Ralic, V Ilic, ... Clinical neurology and neurosurgery 126, 76-81, 2014 | 56 | 2014 |
| Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease PJ Visser, LM Reus, J Gobom, I Jansen, E Dicks, SJ Van der Lee, ... Molecular neurodegeneration 17 (1), 27, 2022 | 50 | 2022 |
| Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset S Hong, D Prokopenko, V Dobricic, F Kilpert, I Bos, SJB Vos, BM Tijms, ... Translational psychiatry 10 (1), 403, 2020 | 50 | 2020 |
| Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2 S Peric, G Mandic-Stojmenovic, E Stefanova, D Savic-Pavicevic, ... Journal of neurology 262, 142-148, 2015 | 50 | 2015 |
| Metabolic syndrome in patients with myotonic dystrophy type 1 M Vujnic, S Peric, S Popovic, N Raseta, V Ralic, V Dobricic, I Novakovic, ... Muscle & Nerve 52 (2), 273-277, 2015 | 47 | 2015 |
| Clinical spectrum of the pentanucleotide repeat expansion in the RFC1 gene in ataxia syndromes M Gisatulin, V Dobricic, C Zühlke, Y Hellenbroich, V Tadic, A Münchau, ... Neurology 95 (21), e2912-e2923, 2020 | 45 | 2020 |
| Genotype–phenotype relations in primary familial brain calcification: systematic MDSGene review A Balck, S Schaake, NS Kuhnke, A Domingo, H Madoev, J Margolesky, ... Movement Disorders 36 (11), 2468-2480, 2021 | 44 | 2021 |
| APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease E Konijnenberg, BM Tijms, J Gobom, V Dobricic, I Bos, S Vos, M Tsolaki, ... Alzheimer's research & therapy 12, 1-11, 2020 | 37 | 2020 |
| Genotype–phenotype relations for the atypical parkinsonism genes: MDSGene systematic review C Wittke, S Petkovic, V Dobricic, S Schaake, ... Movement Disorders 36 (7), 1499-1510, 2021 | 36 | 2021 |
